ATAI Life Sciences takes in $24m

ATAI Life Sciences, a biotech company focused on ending mental illnesses, has raised $24 million in convertible note financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this